Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

BACKGROUND: To date, no symptomatic treatment is available for patients with vascular cognitive impairment (VCI). In the proof-of-principle study Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI), we investigated whether a single dose of a monoaminergic drug (methylphenidate) impro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Leijenaar, Jolien F., Groeneveld, Geert Jan, Klaassen, Erica S., Leeuwis, Anna E., Scheltens, Philip, Weinstein, Henry C., van Gerven, Joop M. A., Barkhof, Frederik, van der Flier, Wiesje M., Prins, Niels D.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947990/
https://ncbi.nlm.nih.gov/pubmed/31910895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0567-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados